Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II

Clinical trial NCT00789685 · COMPLETED

Trial details

NCT number: NCT00789685
Sponsor: Faron Pharmaceuticals Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lung Injury Acute Respiratory Distress Syndrome

Start date: 2009-02-01
Primary completion: 2011-09-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.